Telomerase Activating Compounds for Niche Fertility Applications

Publication ID: 24-11857516_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Telomerase Activating Compounds for Niche Fertility Applications,” Published Technical Disclosure No. 24-11857516_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857516_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,516.

Summary of the Inventive Concept

The present inventive concept discloses specialized telomerase activating compounds and systems for promoting fertility in unique operational environments, such as high-altitude settings, radiation exposure, disaster relief scenarios, and compromised immune systems.

Background and Problem Solved

The original patent disclosed telomerase activating compounds for general fertility applications. However, these compounds may not be effective or suitable for specific, high-stress environments. The present inventive concept addresses this limitation by adapting the compounds and systems for these niche applications, providing a targeted solution for individuals in need.

Detailed Description of the Inventive Concept

The inventive concept comprises telomerase activating compounds and systems tailored for specific, high-stress environments. For instance, Claim 1 discloses a system for promoting fertility in high-altitude environments, comprising a telomerase-activating compound and a delivery mechanism adapted for use at elevated atmospheric pressures. Claim 2 describes a method for enhancing fertility in a subject exposed to radiation, involving the administration of a telomerase-activating compound in conjunction with a radioprotective agent. Similarly, Claims 3-5 detail fertility treatment kits, systems, and methods for disaster relief scenarios, chemotherapy, and compromised immune systems, respectively. These specialized solutions ensure optimal fertility promotion in these unique operational environments.

Novelty and Inventive Step

The present inventive concept introduces novel, non-obvious variations of telomerase activating compounds and systems, specifically designed for niche fertility applications. The inventive step lies in the adaptation of the original compounds and systems to address the unique challenges and requirements of these high-stress environments.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include customized telomerase activating compounds and systems for other specialized environments, such as extreme temperatures, high-stress occupations, or specific genetic conditions. These variations would further expand the scope of the inventive concept, ensuring broad conceptual coverage.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the fertility and reproductive health industries, particularly in niche markets catering to individuals in high-stress environments. Target industries may include disaster relief organizations, high-altitude research stations, and specialized fertility clinics. The inventive concept's unique value proposition lies in its ability to provide targeted, effective fertility solutions for these underserved markets.

CPC Classifications

SectionClassGroup
A A61 A61K31/09
A A61 A61K31/137
A A61 A61K31/4025
A A61 A61K31/4545
A A61 A61K31/5377
A A61 A61K31/66
A A61 A61P15/08

Original Patent Information

Patent NumberUS 11,857,516
TitleTelomerase activating compounds for use in fertility and related applications
Assignee(s)Neuromagen Pharma, Ltd.